Is levosimendan superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction?
In severe and refractory cardiogenic shock complicating acute myocardial infarction, levosimendan, added to current therapy, may contribute to improved survival compared with enoximone.
The results of the present study suggest that PJ may be a useful agent for preventing and treating nicotine addiction.